2020 GA Meeting May 6th Postponed to November due to COVID 19

2019 GA MEETING

The 2019 GA meeting which took place on Wednesday 8 May 2019 in Madrid, Spain was a resounding success. Hosted by FerroGlobe, the meeting which lasted 4 hours saw several deliberations related to the consortium governace, dossier updates and classification & labelling. Some key decisions taken by way of vote are as follows:

Some highlights:

  • Executive Committee: A new Chairmanand  a new 2nd Vice Chairman were appointed, meanwhile the 1st Vice Chiarman was maintained to enure continuity 
  • Dossier updates: Reveal changes in classification and labelling if compared to the 2010 submitted dossiers
  • Approval of the 2018 workplan and budget
  • Brexit and data: Mara will continue to support REACH registration inside and outside the EU (UK REACH inclusive) but at a charge yet to be determined 

New classification for Manganese Ores, reduced; Ferromanganese Slags; Silicomanganese slags

ECHA's request for an OECD 414 - Prenatal developmental toxicity study in rabbit for FeMn slag (the most bioavailable of the UVCB's) resulted in a classifcation for developmental toxicity.  Although the same study in the rats did not show any effects at the highest allowable dose of 1000mg/kg/day, the contrary was observed in rabbits. In rabbits, foetal abnormalities were seen at all treated groups including the lowest dose of 100mg/kg/day leading to a classifction of Repro catergory 2  (H361) for developmental toxicity.

Considering that all there substances are analogues, this classifciation will be readacross Ferromanganese slags (FeMn slags) to Manganese ores, reduced ( Sinter ore) and Silicomanganese slags ( SiMn slags) and eSDS's will be required for all registrants placing these substances on the EU market. 

The classification emanating from this study will trigger the following on the eSDS as a must:

 

Classification

Reproductive toxicity Category 2

Pictogram

 

 

GHS08

Signal word

Warning

Hazard statement

H361d Suspected of damaging fertility or the unborn child).

Precautionary statement Prevention

P201 Obtain special instructions before use.

P202 Do not handle until all safety precautions have been read and understood.

P280 Wear protective gloves/protective clothing/eye protection/face protection

Precautionary statement Response

P308+313 If exposed: Call a POISON CENTER or doctor/physician.


For the above reason, all three registration dossiers will be updated accordingly this year.

For more information please conctact: reach@manganese.org

« Back to news


About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)